Gynecology Robotic Surgery Market Report 2025

The gynecology robotic surgery market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.24 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. Growth during the historical period was driven by the increasing demand for minimally invasive procedures, the rising prevalence of gynecological disorders, greater awareness among women about advanced surgical options, the expansion of private healthcare infrastructure in emerging economies, and the growing adoption of robotic platforms in tertiary care centers.

The gynecology robotic surgery market size is expected to see strong growth in the next few years. It will grow to $4.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Growth in the forecast period is expected to be fueled by the rising geriatric female population with complex gynecologic conditions, increasing healthcare expenditure in developing nations, expanding collaborations between hospitals and medtech companies, growing demand for precision in reproductive surgeries, and a stronger preference for outpatient robotic-assisted hysterectomy. Key trends anticipated during this period include technological advancements in robotic platforms, innovations in single-port robotic systems, increased investment in research and development, the integration of artificial intelligence into robotic surgical systems, and advancements in visualization and ergonomic design of robotic systems.

The rising incidence of gynecological diseases is anticipated to drive the growth of the gynecology robotic surgery market in the coming years. Gynecological diseases are medical conditions that affect the female reproductive organs, including the uterus, ovaries, and cervix, impacting women's reproductive health and overall well-being. The increasing prevalence of these conditions is partly attributed to lifestyle changes such as poor diet, insufficient physical activity, and rising obesity rates, which can disrupt hormonal balance and reproductive health. Robotic surgery in gynecology provides a minimally invasive and highly precise approach to treating these conditions, reducing pain, bleeding, and recovery time for procedures addressing issues such as fibroids, endometriosis, and gynecologic cancers. For example, in January 2025, Cancer Australia, an Australia-based government agency, reported that gynecological cancers were responsible for 2,171 deaths in 2022 and an estimated 2,235 deaths in 2024, with females facing a 1 in 73 (1.4%) lifetime risk of dying from these cancers by age 85. Consequently, the growing prevalence of gynecological diseases is fueling the expansion of the gynecology robotic surgery market.

Leading companies in the gynecology robotic surgery market are focusing on developing advanced robotic-assisted surgery (RAS) systems to improve precision, minimize invasiveness, and enhance patient outcomes. Robotic-assisted surgery systems are advanced medical technologies that enable surgeons to perform complex procedures with greater accuracy and control through minimally invasive techniques using robotic instruments. For instance, in September 2022, CARE Hospitals, an India-based healthcare provider, introduced the Hugo robotic-assisted surgery (RAS) system from Medtronic, becoming the first hospital in the Asia-Pacific region to perform a gynecological procedure using this technology. The Hugo RAS system is a modular, multi-quadrant platform that provides surgeons with enhanced precision, maneuverability through wristed instruments, 3D visualization, and digital surgical video management. This cutting-edge system improves patient outcomes by reducing complications, leaving smaller scars, shortening hospital stays, and accelerating recovery. CARE Hospitals also plans to extend the use of this robotic system to other specialties, such as general surgery and urology, making minimally invasive surgery more widely accessible.

In August 2024, KARL STORZ SE & Co. KG, a Germany-based provider of endoscopy equipment and minimally invasive surgical solutions, acquired Asensus Surgical, Inc. for an undisclosed amount. This acquisition aims to integrate Asensus Surgical’s innovative digital laparoscopic platform into KARL STORZ’s portfolio, enhancing surgical precision, intelligence, and workflow efficiency in operating rooms worldwide. Asensus Surgical, Inc. is a US-based provider of performance-guided surgery technologies that offers robotic surgery systems.

Major players in the gynecology robotic surgery market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical Inc., KARL STORZ SE & Co. KG, Sina Robotics and Medical Innovators Co. Ltd., CMR Surgical Limited, SS Innovations International Inc., Distalmotion SA, Ronovo Surgical Inc., Levita Magnetics International Corp., Titan Medical Inc., Virtual Incision Corporation, Nanjing Perlove Medical Equipment Co. Ltd., Edge Medical Robotics Corporation, Momentis Surgical Ltd., Virtuoso Surgical Inc., Moon Surgical SAS, GynoBotics Inc., and Harbin Sagebot Intelligent Medical Equipment Co. Ltd.

North America was the largest region in the gynecology robotic surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the gynecology robotic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Gynecology robotic surgery is a minimally invasive surgical technique that utilizes advanced robotic systems to assist surgeons in performing procedures on the female reproductive system with improved accuracy, control, and visual clarity. This method enables greater precision through small incisions, often resulting in less postoperative pain, shorter hospital stays, quicker recovery, and a lower risk of complications compared to traditional open surgery.

The primary product categories in gynecology robotic surgery include robotic platforms, instruments and accessories, and robotic platform services. A robotic platform refers to the essential hardware and software system that facilitates robotic surgeries, comprising robotic arms, control consoles, vision systems, and integrated imaging technologies. These platforms are used across various gynecological procedures, including benign surgeries and those related to gynecological oncology, with applications such as hysterectomy, myomectomy, oophorectomy, sacrocolpopexy, and others. The key end users include hospitals, ambulatory surgical centers, and specialty clinics.

The gynecology robotic surgery market research report is one of a series of new reports that provides gynecology robotic surgery market statistics, including gynecology robotic surgery industry global market size, regional shares, competitors with a gynecology robotic surgery market share, detailed gynecology robotic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the gynecology robotic surgery industry. This gynecology robotic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gynecology robotic surgery market consists of revenues earned by entities by providing services such as robotic surgery consultation, preoperative imaging integration, intraoperative navigation support, postoperative monitoring, and surgical training programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The gynecology robotic surgery market also includes sales of products, such as robotic camera systems, 3D vision systems, surgical simulators, ergonomic surgeon consoles, and integrated energy instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.